| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-11 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.2 | 3e-10 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-09 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.2 | 4e-09 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.17 | 6e-09 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.17 | 9e-08 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-07 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-07 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |